For decades, various strategies have been proposed to solve the enigma of
hemoglobinopathies, especially severe cases. However, most of them seem to be lagging in …

It has been suggested that health economists need to improve their methods in order to
meet the challenges of evaluating genomic/genetic tests. In this article, we set out twelve …

Genetic variants affect drug responses, making pre‐emptive genotyping crucial for averting
serious adverse events (SAEs) and treatment failure. However, assessing the benefits of pre …

Pharmacogenomics is rapidly assuming an integral part in modern health care. Still, its
broad applicability relies on the feasibility of performing pharmacogenomic testing in all …

Background. Determining the cost of laboratory tests is a significant factor in the context of
economic analysis and management of clinical diagnostic laboratories. Information about …

There is a plethora of publications showing that adoption of a PGx screening program would
save both money and lives. The economics of an adverse drug reaction (ADR) may vary …

Η φαρμακογονιδιωματική τείνει να αποτελέσει ένα αναπόσπαστο κομμάτι της σύγχρονης
υγειονομικής περίθαλψης. Η ευρεία εφαρμογή της βασίζεται στην αναγκαιότητα διεξαγωγής …